|
ORF cDNA clones
|
CRISPR / TALEN
|
Lentivirus
|
AAV
|
TALE-TF
|
ORF knockin clones
|
|
Antibody
|
Proteins
|
miRNA target clones
|
qPCR primers
|
shRNA clones
|
miRNA products
|
Promoter clones
|
Validated All-in-One™ qPCR Primer for ACKR3(NM_020311.2) Search again
By default, qPCR primer pairs are designed to measure the expression level of the splice variant (accession number) you selected for this gene WITHOUT consideration of other possible variants of this gene. If this gene has multiple variants, and you would like to measure the expression levels of one particular variant, multiple variants, or all variants, please contact us for a custom service project at inquiry@genecopoeia.com.
Validated result:
Summary
This gene encodes a member of the G-protein coupled receptor family. Although this protein was earlier thought to be a receptor for vasoactive intestinal peptide (VIP), it is now considered to be an orphan receptor, in that its endogenous ligand has not been identified. The protein is also a coreceptor for human immunodeficiency viruses (HIV). Translocations involving this gene and HMGA2 on chromosome 12 have been observed in lipomas. [provided by RefSeq].
Gene References into function
- RDC1, which we propose to rename as CXCR7, is a receptor for CXCL12
- RDC1 is a marker for memory B cells, which are competent to become antibody-secreting cells
- characterization of CXCR7, which binds with high affinity to SDF-1 & I-TAC; CXCR7 has properties that affect a spectrum of biological & pathological processes, including cell growth/survival and adhesion, as well as promotion of tumor growth
- CD13 rapidly processed CXCL11, but not CXCL8, to generate truncated CXCL11 forms that had reduced binding, signaling, and chemotactic properties for lymphocytes and CXCR3- or CXCR7-transfected cells.
- CXCR7 has key functions in promoting breast and lung tumor development and progression.
- data demonstrate a role for CXCR7/RDC1 in PCa metastasis and progression and suggest potential targets for therapeutic intervention
- Transcripts of CXCR7 were detected within tumor cells and tumor free lungs, mainly in alveolar macrophage.
- Although CXCR7 is not an intrinsic signaling receptor for CXCL12 on lymphocytes or CD34(+) cells, its blocking can be useful for therapeutic interference with CXCR4-mediated activation of integrins.
- CXCL12 can be a potent growth factor for carcinoma cells by acting on CXCR7.
